AF-3581

N/A

Report date: 2024/12/18 13:39:48
NME

Base Information

Drug NameAF-3581
Drug Alias NameAF-3581
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGlycogen synthase kinase-3 beta inhibitors
TargetsGlycogen synthase kinase-3 beta
Therapy Area/IndicationsBipolar Disorder
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAngelini Pharma
China Registration ClassN/A

Develop Information

Active CompaniesAngelini Pharma
Inactive CompaniesN/A
Active IndicationsBipolar Disorder
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A